Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $17,792 - $21,230
367 Added 9.16%
4,372 $224,000
Q3 2023

Oct 19, 2023

SELL
$57.89 - $64.73 $52,795 - $59,033
-912 Reduced 18.55%
4,005 $232,000
Q2 2023

Jul 17, 2023

BUY
$63.71 - $70.74 $16,437 - $18,250
258 Added 5.54%
4,917 $314,000
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $5,651 - $6,409
86 Added 1.88%
4,659 $322,000
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $2,122 - $2,513
31 Added 0.68%
4,573 $328,000
Q3 2022

Oct 24, 2022

BUY
$0.13 - $76.84 $66 - $39,188
510 Added 12.65%
4,542 $322,000
Q2 2022

Jul 26, 2022

SELL
$72.62 - $79.98 $1,234 - $1,359
-17 Reduced 0.42%
4,032 $310,000
Q1 2022

May 05, 2022

BUY
$61.48 - $73.72 $248,932 - $298,492
4,049 New
4,049 $295,000
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $222,242 - $259,082
-4,144 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$59.17 - $69.31 $18,461 - $21,624
-312 Reduced 7.0%
4,144 $245,000
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $27,549 - $30,001
445 Added 11.09%
4,456 $297,000
Q1 2021

May 04, 2021

BUY
$59.34 - $66.74 $15,191 - $17,085
256 Added 6.82%
4,011 $253,000
Q4 2020

Jan 26, 2021

BUY
$57.74 - $65.43 $216,813 - $245,689
3,755 New
3,755 $232,000
Q1 2020

May 01, 2020

SELL
$46.4 - $67.43 $174,881 - $254,143
-3,769 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $185,472 - $241,932
3,769 New
3,769 $241,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.